No images? Click here The Australian Respiratory Early Surveillance Team for Cystic Fibrosis, or AREST CF, is a team of doctors, nurses, scientists and researchers who are dedicated to the improvement of the general health of children with CF. We have two centres, one in Perth (Perth Children's Hospital) and one in Melbourne (Royal Children's Hospital). ![]() Feature Article:Could Perth lakes hold the secret to fighting antibiotic-resistant superbugs?Associate Professor Anthony Kicic, Head of Airway Epithelial Research at Telethon Kids Institute, is working with his team to give families another weapon in the fight against pseudomonas – the bacteria responsible for causing the common lung infection that children with CF are particularly vulnerable to. ![]() Featured ResearcherDr. Rheanna Mainzer, AREST CF MelbourneDr. Rheanna Mainzer is a Postdoctoral Research Fellow in Biostatistics and Data Science at the Murdoch Children's Research Institute. ![]() In August, the Wal-yan Respiratory Research Centre launched, which is a powerhouse partnership between Telethon Kids Institute, Perth Children’s Hospital Foundation and Perth Children’s Hospital. It is led by Centre Director Professor Stephen Stick. ![]() ![]() Congratulations to Dr. Shiv (AREST CF Melbourne) who has just won the Vertex Mentored Research Innovation Award, one of only four people worldwide to be offered this grant. The Mentored Research Innovation Award provides support for the next generation of CF researchers to conduct a mentored research project in the field of CF and gain the experience needed for future research independence. The selected projects must advance our understanding or treatment of CF. Up to 4 grants of $125,000 over 2 years will be awarded to support research projects mentored by an established CF researcher. The program is designed to support clinical and non clinical research in CF and applications are welcome from across the spectrum in this field. Have you completed the Cystic Fibrosis pulmonary exacerbation survey: which treatment would you choose? Results will help inform how we measure treatment success in the upcoming BEAT-CF trial, which will evaluate the best treatment(s) for pulmonary exacerbations. Find out what our AREST CF researchers and collaborators have been working on Have your say...Share your thoughts with us! We look forward to community feedback and invite you to have your say. What you would like to learn about cystic fibrosis research? |